Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether a specific diet can prevent oxaliplatin-induced neuropathic pain in patients with digestive system cancers has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Neuropathy, Digestive Cancer System | Phase 3 | Status: COMPLETED